COMP and atherosclerosis: Moreover, COMP or COMP-derived peptidomimetics (CCPep24) can protect endothelial cells from flow-induced inflammatory responses by blocking aberrant integrin α5 activation, thus inhibiting atherosclerosis pathogenesis [118].